2019
DOI: 10.3389/fnbeh.2019.00203
|View full text |Cite
|
Sign up to set email alerts
|

Sex, Drugs, and the Medial Amygdala: A Model of Enhanced Sexual Motivation in the Female Rat

Abstract: Methamphetamine (METH) is a psychomotor stimulant that is reported to enhance sexual desire and behavior in both men and women, leading to increases in unplanned pregnancies, sexually-transmitted infections, and even comorbid psychiatric conditions. Here, we discuss our rodent model of increased sexually-motivated behaviors in which the co-administration of METH and the ovarian hormones, estradiol and progesterone, intensify the incentive properties of a sexual stimulus and increases measures of sexually-motiv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
11
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(12 citation statements)
references
References 133 publications
(175 reference statements)
1
11
0
Order By: Relevance
“…Many of these genes are downregulated in meA by cocaine in GHF and SIM, and upregulated by cocaine in SIF. This may reflect an important sex-specific difference in second messenger signaling in response to dopamine within meA, as has been reported (Rudzinskas et al, 2019).…”
Section: Discussionsupporting
confidence: 51%
See 1 more Smart Citation
“…Many of these genes are downregulated in meA by cocaine in GHF and SIM, and upregulated by cocaine in SIF. This may reflect an important sex-specific difference in second messenger signaling in response to dopamine within meA, as has been reported (Rudzinskas et al, 2019).…”
Section: Discussionsupporting
confidence: 51%
“…We focused on meA because of its known sex differences in size (Hines et al, 1992), transcription (Chen et al, 2019), development (De Lorme et al, 2012, mechanisms of sexual differentiation (Argue et al, 2017;Krebs-Kraft et al, 2010;Nugent et al, 2009;Zehr et al, 2006), importance in sex-specific reward-associated behaviors (Chen et al, 2019;Li et al, 2017;Unger et al, 2015) and sensitivity to adolescent stress (Cooke et al, 2000;Hodges et al, 2019). Additionally, while evidence suggests that meA is an important regulator of drug sensitivity in females (Rudzinskas et al, 2019), very little is known about males (Knapska et al, 2007). Therefore, we sought to broaden our understanding of baseline sex-specific transcriptional responses in meA to cocaine in addition to characterizing how those responses are affected by adolescent SI.…”
Section: Discussionmentioning
confidence: 99%
“…Their repertoire of sexual behavior encompasses attractivity, proceptivity, and receptivity. Attractivity and proceptivity behaviors aim to solicit male mounting such as hopping, darting, and ear wiggling (reviewed in Micevych and Meisel, 2017;Rudzinskas et al, 2019). In response to male mounting, the female displays receptivity through arching their back, a behavior termed lordosis (reviewed in Micevych and Meisel, 2017).…”
Section: Rodent Female Sexual Behaviormentioning
confidence: 99%
“…Research on sexual behavior benefited greatly from rodent models, including the discovery of several brain regions important for sexual behavior (Snoeren et al, 2014;Rudzinskas et al, 2019). Within these regions, glutamate acts as a pivotal neurotransmitter for sexual behavior (reviewed in Hull and Dominguez, 2006;Dominguez, 2009;Will et al, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…The progesterone receptor (PR: NCBI Gene ID:18667) is a member of the steroid receptor superfamily and plays essential roles in female reproductive events, such as the establishment and maintenance of pregnancy, menstrual cycle regulation, sexual behavior, and development of mammary glands. It is also responsible for developing the central nervous system by the regulation of cell proliferation and differentiation via a wide range of physiological process modulated by progesterone-mediated classical ligand-binding or non-classical novel non-genomic pathways (Garg et al, 2017;Leehy et al, 2018;Wu et al, 2018;Cenciarini and Proietti, 2019;González-Orozco and Camacho-Arroyo, 2019;Hawley and Mosura, 2019;Rudzinskas et al, 2019). In the clinic, steroidal PR agonists have been used in oral contraception and postmenopasusal hormone therapy (Fensome et al, 2005;Afhüppe et al, 2009;Lee et al, 2020).…”
Section: Introductionmentioning
confidence: 99%